Short Interest in Janone Inc. (NASDAQ:ALTS) Decreases By 50.4%

Janone Inc. (NASDAQ:ALTSGet Free Report) was the recipient of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 62,900 shares, a decrease of 50.4% from the December 31st total of 126,700 shares. Approximately 0.5% of the company’s shares are sold short. Based on an average daily volume of 198,900 shares, the days-to-cover ratio is currently 0.3 days.

Janone Price Performance

Shares of ALTS opened at $5.73 on Friday. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 1.96. Janone has a 12-month low of $0.50 and a 12-month high of $7.09. The firm has a 50-day moving average price of $4.30.

About Janone

(Get Free Report)

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments.

Featured Articles

Receive News & Ratings for Janone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Janone and related companies with MarketBeat.com's FREE daily email newsletter.